Matches in Wikidata for { <http://www.wikidata.org/entity/Q38162877> ?p ?o ?g. }
- Q38162877 description "article científic" @default.
- Q38162877 description "article scientifique" @default.
- Q38162877 description "articol științific" @default.
- Q38162877 description "articolo scientifico" @default.
- Q38162877 description "artigo científico" @default.
- Q38162877 description "artigo científico" @default.
- Q38162877 description "artigo científico" @default.
- Q38162877 description "artikel ilmiah" @default.
- Q38162877 description "artikull shkencor" @default.
- Q38162877 description "artículo científico" @default.
- Q38162877 description "artículu científicu espublizáu en 2013" @default.
- Q38162877 description "bilimsel makale" @default.
- Q38162877 description "scienca artikolo" @default.
- Q38162877 description "scientific article published on January 2013" @default.
- Q38162877 description "scientific article published on January 2013" @default.
- Q38162877 description "scientific article published on January 2013" @default.
- Q38162877 description "vedecký článok" @default.
- Q38162877 description "vetenskaplig artikel" @default.
- Q38162877 description "videnskabelig artikel" @default.
- Q38162877 description "vitenskapelig artikkel" @default.
- Q38162877 description "vitskapeleg artikkel" @default.
- Q38162877 description "vědecký článek" @default.
- Q38162877 description "wetenschappelijk artikel" @default.
- Q38162877 description "wissenschaftlicher Artikel" @default.
- Q38162877 description "наукова стаття, опублікована в січні 2013" @default.
- Q38162877 description "научная статья" @default.
- Q38162877 description "научни чланак" @default.
- Q38162877 description "מאמר מדעי" @default.
- Q38162877 description "مقالة علمية نشرت في يناير 2013" @default.
- Q38162877 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38162877 name "Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials" @default.
- Q38162877 name "Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials" @default.
- Q38162877 name "Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials" @default.
- Q38162877 type Item @default.
- Q38162877 label "Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials" @default.
- Q38162877 label "Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials" @default.
- Q38162877 label "Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials" @default.
- Q38162877 prefLabel "Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials" @default.
- Q38162877 prefLabel "Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials" @default.
- Q38162877 prefLabel "Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials" @default.
- Q38162877 P1433 Q38162877-91599806-82CB-4E15-ACBA-93BC9949269E @default.
- Q38162877 P1476 Q38162877-8DF13083-9C27-4620-B81A-B3B25A55E421 @default.
- Q38162877 P2093 Q38162877-121B13B0-0887-4D88-B26E-BE219559BD78 @default.
- Q38162877 P2093 Q38162877-4B54E1B3-699E-42CB-A1FB-1C6AA71C85A7 @default.
- Q38162877 P2093 Q38162877-4C190084-E408-4F81-90D3-3547379292C9 @default.
- Q38162877 P2093 Q38162877-6660EB26-A01A-432A-B43B-E03D683BD910 @default.
- Q38162877 P2093 Q38162877-6F68354B-0861-4F09-819B-9FA62FFBB86E @default.
- Q38162877 P2093 Q38162877-B65BF80B-E3B1-4FE8-99C0-C215F7336D95 @default.
- Q38162877 P2093 Q38162877-BB6F0240-6142-4F4B-B2F2-168E87E8FC99 @default.
- Q38162877 P2093 Q38162877-E9B724E4-5B33-44CD-A3B6-2A63E6E14B6F @default.
- Q38162877 P2093 Q38162877-FA38BFCB-5D49-4F75-9317-16F0E7FEAF58 @default.
- Q38162877 P2860 Q38162877-096A01D1-4737-4E2D-9F9D-25C746302865 @default.
- Q38162877 P2860 Q38162877-0E8A0036-FE77-43E0-89BC-37B1430A94CA @default.
- Q38162877 P2860 Q38162877-15E3E509-F469-421D-8E76-CA91D532771A @default.
- Q38162877 P2860 Q38162877-1D0F86AB-BE26-4C5E-BADC-F8338ECFBE6A @default.
- Q38162877 P2860 Q38162877-231A532D-AA2E-4B1D-BF52-8BCA45032519 @default.
- Q38162877 P2860 Q38162877-2EA00B24-6096-4CC9-A6F3-27D9040761A6 @default.
- Q38162877 P2860 Q38162877-35741481-26CD-4250-92BC-47E3FB1EAE0A @default.
- Q38162877 P2860 Q38162877-39C44C2D-0DCA-45D3-B796-B94071F652C9 @default.
- Q38162877 P2860 Q38162877-3C923C94-09DE-4E05-80DD-792E03D02EB6 @default.
- Q38162877 P2860 Q38162877-45502C2C-4B45-4CA7-BC0E-E1F4111AC865 @default.
- Q38162877 P2860 Q38162877-4AA94CF2-035A-4E87-8A09-57F78E6D498A @default.
- Q38162877 P2860 Q38162877-4BFC20B1-4955-43A0-AF9F-E353246AE410 @default.
- Q38162877 P2860 Q38162877-5A4BF35A-0C46-44AB-8706-27266D8CBFBC @default.
- Q38162877 P2860 Q38162877-62F19116-1C8A-460D-9842-771D32E20D54 @default.
- Q38162877 P2860 Q38162877-7596BB01-EA91-430A-BA82-B7FD1831C845 @default.
- Q38162877 P2860 Q38162877-76969B27-3D54-4B69-AE9C-A427DF3D47C3 @default.
- Q38162877 P2860 Q38162877-78906891-20C0-4C96-8B6C-81BB253023AC @default.
- Q38162877 P2860 Q38162877-7F3F813C-49C3-4637-80D0-8CEB6E4FEDE9 @default.
- Q38162877 P2860 Q38162877-8072C82B-406D-41DC-82A5-324D79FDB163 @default.
- Q38162877 P2860 Q38162877-86980791-E142-44F1-95B1-4D4808533712 @default.
- Q38162877 P2860 Q38162877-937364A2-7E18-421C-AADA-712072CFEE92 @default.
- Q38162877 P2860 Q38162877-9876F70A-2122-4813-A191-DB4914979438 @default.
- Q38162877 P2860 Q38162877-9BA5A9F8-6E5A-4670-B64E-3599738AC439 @default.
- Q38162877 P2860 Q38162877-9E40D7DD-D623-4748-9C64-38D35EC68C16 @default.
- Q38162877 P2860 Q38162877-ACDB8596-96E1-4E09-88D7-F967C532DB3D @default.
- Q38162877 P2860 Q38162877-B3772CBA-9AD1-46F1-869E-8CC073769C00 @default.
- Q38162877 P2860 Q38162877-B4C94E7B-A986-430F-BF2F-A983403B7D00 @default.
- Q38162877 P2860 Q38162877-D756B20B-3192-4967-B5B9-F11A06BDA8D6 @default.
- Q38162877 P2860 Q38162877-DD4CA80A-71B1-443E-AB0E-9A98C6834DC3 @default.
- Q38162877 P2860 Q38162877-E06CCB16-A37A-4387-AC90-6CC5A62B8D9A @default.
- Q38162877 P2860 Q38162877-E7775219-BBDF-4E95-866D-1A95F223EFC5 @default.
- Q38162877 P2860 Q38162877-ED348D1C-3F5C-44D2-9E83-99B10BDDBEEC @default.
- Q38162877 P2860 Q38162877-F3478A62-E097-42B9-8C0B-525D1E9A7123 @default.
- Q38162877 P2860 Q38162877-FCD80627-13EC-4B5C-B447-52050169DB0D @default.
- Q38162877 P304 Q38162877-8E592BA1-98A1-41BD-BF3E-3D2D7E810583 @default.
- Q38162877 P31 Q38162877-C8EA3A94-CA52-48C1-AB3B-CF1644B73E00 @default.
- Q38162877 P356 Q38162877-EC5EE9CD-638C-4CB9-9E5E-19B91CB67806 @default.
- Q38162877 P433 Q38162877-E8584840-6AAE-4B83-8020-483ED013405B @default.
- Q38162877 P478 Q38162877-5651EC12-C032-4BF9-A3BC-9B29B1F9D72A @default.
- Q38162877 P50 Q38162877-ECA1D706-139F-49ED-83F1-922C7D5DEF87 @default.
- Q38162877 P577 Q38162877-83B9B36A-10AA-462B-9901-39B23B3E5B26 @default.
- Q38162877 P698 Q38162877-E4F1B719-2598-4BAB-B9CE-C1E68E234B2B @default.
- Q38162877 P921 Q38162877-AC45FDCF-6CEE-4403-8CD1-AD1EC1DF1D9C @default.
- Q38162877 P356 CER.12.72 @default.
- Q38162877 P698 24236524 @default.
- Q38162877 P1433 Q22080407 @default.
- Q38162877 P1476 "Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials" @default.
- Q38162877 P2093 "Erin Wong" @default.
- Q38162877 P2093 "Florence Mok" @default.